Research Projects & Grants

For Profit Organization

• Systemic Lupus Erythematosus (SLE) prospective observational cohort study (SPOCS): Prospective observational cohort of patients with moderate-to-severe SLE to characterize cross-sectional and longitudinal disease activity, treatment patterns and effectiveness, outcomes and comorbidities, healthcare resource utilization, and the impact of SLE on quality of life by type I interferon gene expression, Role: Investigator, AstraZeneca (UK HQ), (10/2022 - 10/2023) Status: Completed
• A randomized, double-blinded, placebo-controlled study of the effect of XmAB®5871 on systemic Lupus erythematosus disease activity, Role: Investigator, Xencor, Inc., (05/2018 - 05/2019) Status: Completed

Internal

• Vertebral compression fractures and osteoporosis: the awareness and follow-up in providing comprehensive patient care, Role: PI, LLU Dept. of Medicine, (07/2023) Status: Approved
• Primary Osteoporosis Prevention: Practice Patterns at an Academic Medical Center with a Fracture Liaison Service, Role: PI, LLU Dept. of Medicine, (03/2022) Status: Approved
• Retrospective analysis of the effectiveness of Benlysta in Neuropsychiatric Lupus patients, Role: PI, LLU Dept. of Medicine, (12/2020) Status: Approved
• SARS-CoV-related Cytokine Release Syndrome (CoV-CRS): Identification and Evaluation of treatment response to biologic therapy, Role: Investigator, LLU Dept. of Medicine, (07/2020) Status: Approved
• Effects of intermittent fasting on established autoimmune disease, Role: PI, LLU Dept. of Medicine, (05/2020) Status: Approved
• Screening for hydroxychloroquine retinopathy, Role: PI, LLU Dept. of Medicine, (10/2019) Status: Approved
• An investigation of low Alkaline Phosphatas and clinical significance, Role: PI, LLU Dept. of Medicine, (06/2019) Status: Approved
• Epidemiologic comparison of ANCA vasculitis in rural health care and urban health care, Role: PI, LLU Dept. of Medicine, (04/2019) Status: Approved